CareDx, Inc.
CDNA· Nasdaq
Filed Feb 24, 2021 · 10-K · 55 days after period end · 0001217234-21-000046
derived · Computed from the longer spans the company filed.
| Metric | Q4 2020dderived from reported figures | Q4 2019 | Q4 2018 | Q4 2017 |
|---|---|---|---|---|
| Revenue | $58.64M | $35.82M | $23.51M | $12.50M |
| Net Income | -$3.52M | -$4.78M | -$3.76M | -$31.67M |
| EPS Diluted | — | -$0.11 | -$0.09 | -$1.13 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
CareDx, Inc. · CIK 1217234 · Engraved from SEC EDGAR
ended Dec 31, 2020 · filed Feb 24, 2021 · 55 d after period end